Aeroallergen sensitization in school-age children with allergic rhinitis: What has changed during the COVID-19 pandemic?

• Published in: Allergologia et immunopathologia 2023-01, Vol.51 (3), p.68-79
• Main Authors: Gunaydin, Nursen Cigerci, Tanc, Ceren, Celiker, Ezgi Tanburoglu, Kacmaz, Sule Guler, Samanci, Nedim, Nalbantoglu, Aysin, Nalbantoglu, Burcin
• Format: Article
• Language: English
• Subjects: Allergens; Allergies; Asthma; Asthma - epidemiology; Child; Coronaviruses; COVID-19; COVID-19 - epidemiology; Disease; Families & family life; Family medical history; Hay fever; Humans; Laboratories; Pandemics; Patients; Retrospective Studies; Rhinitis; Rhinitis, Allergic - diagnosis; Rhinitis, Allergic - epidemiology; Severe acute respiratory syndrome coronavirus 2; Skin Tests; Statistical analysis; Variables
• ISSN: 0301-0546; 1578-1267; 0301-0546
• DOI: 10.15586/aei.v51i3.832

Pandemic period may affect aeroallergen sensitization. The study aimed to investigate changes in allergen sensitivities of skin prick test (SPT) in patients with allergic rhinitis (AR) during pandemic and to evaluate relationship with disease severity. In all, 164 AR patients with or without asthma, aged 6-17 years, who have undergone SPTs prior to the pandemic and after October 1, 2021 (18th month of the pandemic), were evaluated retrospectively. The wheal size of allergens in performed SPTs during and prior to the pandemic were compared. Detected changes in allergen sensitivities via SPT results were compared with changes in the disease severity parameters (AR severity, asthma severity, and the number of asthma exacerbations per year), frequency of upper respiratory tract infections and antibiotic use, laboratory parameters, demographic characteristics, and visual analogue scores (VAS). House dust mites (HDMs), cat, pollen, , and sensitization increased in AR patients during the Coronavirus disease 2019 (COVID-19) pandemic. HDM, mold, and pollen wheal diameters increased in SPTs. Proportion of polysensitization increased during the pandemic, compared to pre-pandemic period (9.1% vs 3%; P < 0.001), and number of non-sensitized patients decreased during the pandemic period compared to the pre-pandemic period (7.9% vs 22.6%; P < 0.001). An increase in HDM sensitivity in SPTs was correlated with VAS for nasal blockage, and an increase in cat sensitivity was correlated with VAS for all nasal symptoms. We believe that inhalant allergen sensitization might have been affected by the lifestyle changes of patients during the pandemic. Hence, it is important to evaluate patients for allergen sensitization, especially patients with moderate/severe AR, to revise disease control measurements.